Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.10 billion. The enterprise value is $11.41 billion.
Important Dates
The next confirmed earnings date is Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Feb 24, 2025 |
Share Statistics
Organon & Co. has 257.95 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Current Share Class | 257.95M |
| Shares Outstanding | 257.95M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 80.85% |
| Float | 256.82M |
Valuation Ratios
The trailing PE ratio is 3.61 and the forward PE ratio is 3.13. Organon & Co.'s PEG ratio is 1.77.
| PE Ratio | 3.61 |
| Forward PE | 3.13 |
| PS Ratio | 0.46 |
| Forward PS | 0.48 |
| PB Ratio | 6.28 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.00 |
| P/OCF Ratio | 3.25 |
| PEG Ratio | 1.77 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.47, with an EV/FCF ratio of 14.94.
| EV / Earnings | 13.21 |
| EV / Sales | 1.78 |
| EV / EBITDA | 6.47 |
| EV / EBIT | 7.67 |
| EV / FCF | 14.94 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 19.14.
| Current Ratio | 1.60 |
| Quick Ratio | 0.80 |
| Debt / Equity | 19.14 |
| Debt / EBITDA | 4.94 |
| Debt / FCF | 11.83 |
| Interest Coverage | 2.86 |
Financial Efficiency
Return on equity (ROE) is 429.85% and return on invested capital (ROIC) is 10.13%.
| Return on Equity (ROE) | 429.85% |
| Return on Assets (ROA) | 7.39% |
| Return on Invested Capital (ROIC) | 10.13% |
| Return on Capital Employed (ROCE) | 14.33% |
| Revenue Per Employee | $640,300 |
| Profits Per Employee | $86,400 |
| Employee Count | 10,000 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 2.04 |
Taxes
| Income Tax | -57.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.99% in the last 52 weeks. The beta is 0.69, so Organon & Co.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -34.99% |
| 50-Day Moving Average | 14.14 |
| 200-Day Moving Average | 16.98 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 4,090,965 |
Short Selling Information
The latest short interest is 15.13 million, so 5.87% of the outstanding shares have been sold short.
| Short Interest | 15.13M |
| Short Previous Month | 17.84M |
| Short % of Shares Out | 5.87% |
| Short % of Float | 5.89% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.40 billion and earned $864.00 million in profits. Earnings per share was $3.33.
| Revenue | 6.40B |
| Gross Profit | 3.72B |
| Operating Income | 1.49B |
| Pretax Income | 655.00M |
| Net Income | 864.00M |
| EBITDA | 1.77B |
| EBIT | 1.49B |
| Earnings Per Share (EPS) | $3.33 |
Full Income StatementBalance Sheet
The company has $675.00 million in cash and $9.04 billion in debt, giving a net cash position of -$8.36 billion or -$32.41 per share.
| Cash & Cash Equivalents | 675.00M |
| Total Debt | 9.04B |
| Net Cash | -8.36B |
| Net Cash Per Share | -$32.41 |
| Equity (Book Value) | 472.00M |
| Book Value Per Share | 1.83 |
| Working Capital | 1.63B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $939.00 million and capital expenditures -$175.00 million, giving a free cash flow of $764.00 million.
| Operating Cash Flow | 939.00M |
| Capital Expenditures | -175.00M |
| Free Cash Flow | 764.00M |
| FCF Per Share | $2.96 |
Full Cash Flow StatementMargins
Gross margin is 58.02%, with operating and profit margins of 23.24% and 13.49%.
| Gross Margin | 58.02% |
| Operating Margin | 23.24% |
| Pretax Margin | 12.60% |
| Profit Margin | 13.49% |
| EBITDA Margin | 27.57% |
| EBIT Margin | 23.24% |
| FCF Margin | 11.93% |
Dividends & Yields
This stock pays an annual dividend of $1.12, which amounts to a dividend yield of 9.32%.
| Dividend Per Share | $1.12 |
| Dividend Yield | 9.32% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 33.63% |
| Buyback Yield | -1.13% |
| Shareholder Yield | 8.57% |
| Earnings Yield | 28.30% |
| FCF Yield | 25.03% |
Dividend DetailsAnalyst Forecast
The average price target for Organon & Co. is $20.60, which is 71.45% higher than the current price. The consensus rating is "Hold".
| Price Target | $20.60 |
| Price Target Difference | 71.45% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 0.93% |
| EPS Growth Forecast (5Y) | 5.94% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.35 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 5 |